NASDAQ:IKT   Inhibikase Therapeutics, Inc
Inhibikase Therapeutics Inc is a clinical stage pharmaceutical company developing therapeutics for Parkinson's Diseases and related disorders inside and outside the brain. Its pipeline product, IkT-148009, targets underlying disease mechanisms to reverse the course of Parkinson's disease and the GI complications of Parkinson's disease.

If you understand the idea,🎯 press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
Trade closed: target reached: closed the trade with the profit

Slow and Steady Wins the Race. Feeling alone? Join professional traders in our discord now 🟢 Have questions? write to me in Facebook 👉